Xtl Biopharmaceuticals (XTLB) Return on Sales [ROS] (2011 - 2024)
Xtl Biopharmaceuticals (XTLB) recorded Return on Sales [ROS] of 202.42% in the quarter ended Dec 31, 2024.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Return on Sales [ROS] (2011 - 2024) Analysis & Trends
For the year ended Dec 31, 2024, Xtl Biopharmaceuticals reported Return on Sales [ROS] of -171.84%.
- Annual Return on Sales [ROS] has a four-year change of +8446.34 percentage points (years ended Dec 2020 to Dec 2024).
- Across earlier years, Return on Sales [ROS] came in at -8618.18% in the year ended Dec 31, 2020.
- The figure for the quarter ended Dec 31, 2024 is the highest quarterly Return on Sales [ROS] in data going back to the quarter ended Jun 30, 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 28.37% |
| 10 | Xtl Biopharmaceuticals | 2.13 Bn | 2.13 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 202.42% |
| Mar 31, 2022 | -17,466.67% |
| Mar 31, 2021 | -308.70% |
| Dec 31, 2020 | -2,141.67% |
| Mar 31, 2020 | -3,671.43% |
| Sep 30, 2014 | -127.87% |
| Jun 30, 2014 | -106.05% |
| Mar 31, 2014 | -101.19% |
| Dec 31, 2013 | 104.36% |
| Sep 30, 2013 | 175.26% |
| Jun 30, 2013 | -195.31% |
| Mar 31, 2013 | -137.15% |
| Dec 31, 2012 | -93.28% |
| Sep 30, 2012 | -48.10% |
| Jun 30, 2012 | -138.46% |
| Mar 31, 2012 | 28.06% |
| Dec 31, 2011 | -38.56% |
| Sep 30, 2011 | -114.37% |
| Jun 30, 2011 | -67.41% |
API Access
Xtl Biopharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();